adult cap factories

Lexaria Bioscience Corp. Announces Participation in the Benzinga Global Small Cap Conference

Lexaria Bioscience Corp. (NASDAQ: LEXX) will be presenting at the Benzinga Global Small Cap Conference taking place on December 8-9, 2021. We invite our shareholders and all interested parties to explore investment opportunities within the global small cap space.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/december-2021-global/.

About the Benzinga Global Small Cap Conference

The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined educational modules, take a look at a curated group of small cap investment opportunities, and connect with the global small cap audience in an intimate, virtual setting.

For more information and/or to register for the conference please visit: https://www.benzinga.com/events/small-cap/december-2021-global/.

We look forward to seeing you there.

For further information:

Lexaria Bioscience Corp.
George Jurcic
250-765-6424, ext 202
ir@lexariabioscience.com
www.lexariabioscience.com

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Lexaria Bioscience

Lexaria Bioscience

Overview

Lexaria Bioscience Corp. (NASDAQ:LEXX) is a biotechnology company focused on its proprietary drug delivery technology DehydraTECH™. The company has been granted 18 patents internationally and submitted over 60 patent applications. Operating on an out-licensing and royalty business model, the company generates most of its revenue from very high profit-margin royalties by licensing its patented DehydraTECH™ technology to other companies.

Lexaria is exploring several verticals for its DehydraTECH™ technology:

Keep reading...Show less

Out-Licensing Patented Biotechnologies

Latest Press Releases

Related News